Plain-English translation of NCT06666816 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is watching how people with neuromuscular diseases (like muscular dystrophy, spinal muscular atrophy, and Charcot-Marie-Tooth disease) walk and move throughout their day. Researchers want to understand fatigue better by measuring walking patterns during clinic visits and tracking everyday activity using a small wearable sensor worn for one week. The goal is to find objective ways to measure fatigue that doctors can use in the future.
People with neuromuscular diseases often experience fatigue, but doctors currently have limited tools to measure it objectively. This study aims to identify physical markers of fatigue that could help doctors better understand and monitor the disease.
You likely qualify if…
You likely don't qualify if…
You would visit a clinic to perform walking tests that measure your gait and fatigue, which takes a few hours. Then you would wear a small sensor on your body for one week during your normal daily activities to track your movement and physical activity patterns. A control group of people without neuromuscular disease will also participate so researchers can compare results.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Italy
IRCCS Eugenio Medea
Enrollment target
~120 participants
Started
October 2017
Primary completion
December 2026
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Fabio A Storm, PhD
IRCCS Eugenio Medea
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.